Assessment of lung involvement

Matucci-Cerinic, A; D'Angelo, S; Denton, CP; Vlachoyiannopulos, P; Silver, R

dc.contributor.author	Matucci-Cerinic, A	en
dc.contributor.author	D'Angelo, S	en
dc.contributor.author	Denton, CP	en
dc.contributor.author	Vlachoyiannopulos, P	en
dc.contributor.author	Silver, R	en
dc.date.accessioned	2014-03-01T01:53:06Z
dc.date.available	2014-03-01T01:53:06Z
dc.date.issued	2003	en
dc.identifier.issn	0392-856X	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/26846
dc.subject	alveolitis	en
dc.subject	interstitial fibrosis	en
dc.subject	pulmonary hypertension	en
dc.subject.classification	Rheumatology	en
dc.subject.other	PROGRESSIVE SYSTEMIC-SCLEROSIS	en
dc.subject.other	RESOLUTION COMPUTED-TOMOGRAPHY	en
dc.subject.other	EVALUATING PULMONARY FIBROSIS	en
dc.subject.other	EXHALED NITRIC-OXIDE	en
dc.subject.other	BRONCHOALVEOLAR LAVAGE	en
dc.subject.other	SERUM LEVELS	en
dc.subject.other	INTERSTITIAL PNEUMONIA	en
dc.subject.other	PROTEIN-D	en
dc.subject.other	DISEASE	en
dc.subject.other	ALVEOLITIS	en
dc.title	Assessment of lung involvement	en
heal.type	journalArticle	en
heal.language	English	en
heal.publicationDate	2003	en
heal.abstract	The aim of the subcommittee was to identify a core set of feasible variables reflecting the occurrence of interstitial and/or vascular lung disease. After extensive review of published studies and critical assessment of candidate variables, the subcommittee identified the minimal requirements to assess lung disease. Two core sets of variables are provided: the first concerns interstitial lung disease; the second pulmonary vascular disease.	en
heal.publisher	CLINICAL & EXPER RHEUMATOLOGY	en
heal.journalName	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	en
dc.identifier.isi	ISI:000183888300005	en
dc.identifier.volume	21	en
dc.identifier.issue	3	en
dc.identifier.spage	S19	en
dc.identifier.epage	S23	en